
News|Articles|May 1, 2002
Milrinone for acute exacerbations of CHF: Routine use not recommended
Ratherthan shortening the hospital stay and improving clinical outcomes, a 48-hour infusion of milrinone was associated with increased early treatment failure-particularly due to the development of arrhythmias and hypotension-in patients hospitalized with acute exacerbations of chronic heart failure (CHF).
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Simtriyo, the first triple reuptake inhibitor for ADHD
2
Long-acting HIV treatment still out of reach in low- and middle-income countries, says UCSF's Monica Gandhi | AIDS 2026
3
Long-acting cabotegravir PrEP users report no HIV infections, high satisfaction | AIDS 2026
4
Scientifically, lenacapavir PrEP takes a victory lap. But now worries about access | AIDS 2026
5


























